As the Federal Reserve holds interest rates steady, the U.S. stock market has seen fluctuations, with major indices experiencing both gains and losses amid ongoing earnings reports from big tech companies. For investors looking beyond these large-cap stocks, penny stocks—often representing smaller or newer companies—remain a relevant area of interest despite their somewhat outdated label. These stocks can offer a blend of affordability and growth potential, especially when backed by robust financials, making them an intriguing option for those seeking opportunities outside the mainstream market narrative.
Name | Share Price | Market Cap | Financial Health Rating |
QuantaSing Group (NasdaqGM:QSG) | $3.08 | $121.14M | ★★★★★★ |
BAB (OTCPK:BABB) | $0.9115 | $6.53M | ★★★★★★ |
ZTEST Electronics (OTCPK:ZTST.F) | $0.27829 | $10.41M | ★★★★★★ |
Permianville Royalty Trust (NYSE:PVL) | $1.47 | $48.18M | ★★★★★★ |
North European Oil Royalty Trust (NYSE:NRT) | $4.54 | $42M | ★★★★★★ |
Imperial Petroleum (NasdaqCM:IMPP) | $2.76 | $82.81M | ★★★★★★ |
BTCS (NasdaqCM:BTCS) | $3.09 | $53.96M | ★★★★★★ |
Golden Growers Cooperative (OTCPK:GGRO.U) | $4.50 | $67.38M | ★★★★★★ |
CBAK Energy Technology (NasdaqCM:CBAT) | $0.891 | $80.95M | ★★★★★☆ |
Smith Micro Software (NasdaqCM:SMSI) | $1.29 | $22.88M | ★★★★★☆ |
Click here to see the full list of 711 stocks from our US Penny Stocks screener.
Here we highlight a subset of our preferred stocks from the screener.
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Planet Image International Limited, with a market cap of $276.95 million, manufactures and sells compatible toner cartridges under white-label or third-party brands across North America, Europe, and other international markets.
Operations: The company generates revenue of $153.28 million from its Printers & Related Products segment.
Market Cap: $276.95M
Planet Image International, with a market cap of US$276.95 million, presents both opportunities and challenges typical of penny stocks. The company's short-term assets of US$129.2 million comfortably cover its liabilities, indicating sound financial health in the near term. Despite this stability, the stock has experienced high volatility over the past three months and increased weekly volatility over the past year. Trading at 47.2% below estimated fair value suggests potential undervaluation; however, earnings growth has decelerated recently to 1.6%, underperforming industry averages. The board is experienced but lacks comprehensive data on management tenure for further insights into leadership stability.
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Shattuck Labs, Inc. is a clinical-stage biotechnology company focused on developing therapeutics for cancer and autoimmune diseases in the United States, with a market cap of $56.33 million.
Operations: The company generates its revenue from the biotechnology segment, amounting to $6.44 million.
Market Cap: $56.33M
Shattuck Labs, with a market cap of US$56.33 million, exemplifies the volatility and risk associated with penny stocks. The company's financial position is bolstered by short-term assets of US$98.7 million surpassing its liabilities, yet it remains unprofitable with significant losses over the past five years. Although debt-free and trading at 95.5% below estimated fair value, Shattuck faces challenges such as declining earnings forecasts and less than a year of cash runway if current trends continue. Recent presentations at major healthcare conferences highlight efforts to engage stakeholders amid ongoing financial hurdles in achieving profitability.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Yatsen Holding Limited, with a market cap of approximately $329.18 million, develops and sells beauty products under various brands such as Perfect Diary and Little Ondine in the People’s Republic of China.
Operations: The company generates revenue of CN¥3.32 billion from its operations in the People's Republic of China.
Market Cap: $329.18M
Yatsen Holding Limited, with a market cap of approximately US$329.18 million, operates in the beauty products sector and is characteristic of penny stocks due to its current unprofitability and reduced sales year-over-year. Despite being debt-free and having short-term assets (CN¥2.4 billion) that cover both short-term (CN¥576.3 million) and long-term liabilities (CN¥213.4 million), the company faces challenges with a negative return on equity (-22.5%). Recent executive changes may impact strategic direction, while financial guidance for Q4 2024 indicates modest revenue growth expectations amidst ongoing efforts to reduce losses over time.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NasdaqCM:YIBO NasdaqGS:STTK and NYSE:YSG.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.